Head to head
Braskem vs Dow Inc
Side-by-side on the measures that matter, with a plain-English read. Full detail: BAK · DOW
BAK
Braskem
1.77+5.99%
1-year price shape — -30% over the period
Quant Rating F · 36/100
vs
DOW
Dow Inc
27.77-1.38%
1-year price shape — +29% over the period
Quant Rating D · 66/100
1-year performance, rebased to 100
Dow Inc edges it on the scoreable measures. Dow Inc has the highest Quant Rating (66); Dow Inc has done best over the past year (+29%); Dow Inc pays the highest dividend yield.
| BAK | DOW | |
|---|---|---|
| Snapshot | ||
| Sector | Chemicals | -- |
| Last price | 1.77 | 27.77 |
| Change today | +5.99% | -1.38% |
| 1-year return | -30.0% | +29.4% |
| Market cap | $705.32M | $20.06B |
| 52-week range | 1.40 – 5.40 | 19.91 – 41.82 |
| Valuation | ||
| P/E (TTM) | -0.64 | -15.17 |
| P/E percentile, own 5-yr range | 66th | 11th |
| P/B | -0.28 | 1.26 |
| Dividend yield | 0.00% | 5.04% |
| Profitability & growth | ||
| EPS (TTM) | -4.94 | -3.70 |
| Net profit (TTM) | $-1.97B | $-2.67B |
| Revenue (TTM) | $70.60B | $41.32B |
| Revenue growth (YoY) | +21.6% | +19.7% |
| Gross margin | 8.9% | 9.9% |
| Operating margin | 6.0% | 3.7% |
| Net margin | -7.8% | -3.1% |
| Free cash flow (TTM) | $-8.94B | $1.60B |
| Ownership & sentiment | ||
| Institutional ownership | 99.3% | 79.4% |
| Insider activity (12mo) | 0 buy / 0 sell | 38 buy / 9 sell |
| Short interest (% of float) | 1.1% | 4.9% |
| Analyst consensus | 100% sell (2) | 33% buy / 58% hold / 8% sell (12) |
| Analyst price target | $2 (-15%) | $35 (+25%) |
| StockVane view | ||
| StockVane Quant Rating | F (36) | D (66) |
| Company | ||
| Employees | 8,233 | 34,600 |
| Founded | 1972 | 1897 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.